Prophylactic Dimenhydrinate for Intraoperative Nausea and Vomiting
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study will be to determine whether an intravenous dose of dimenhydrinate
(also known as Gravol), given before the induction of spinal anesthesia, will decrease the
incidence of intraoperative nausea and vomiting in patients undergoing Cesarean delivery.
This medication is commonly given during and after the surgery if required, but it is not
known whether a preventative dose will decrease the overall incidence of these side effects.
Phase:
N/A
Details
Lead Sponsor:
Samuel Lunenfeld Research Institute, Mount Sinai Hospital